billS248Event Friday, January 24, 2025Analyzed

Sustainable Cardiopulmonary Rehabilitation Services in the Home Act

Bullish

Summary

The Sustainable Cardiopulmonary Rehabilitation Services in the Home Act (S.248) permanently codifies COVID-era telehealth flexibilities for Medicare-covered cardiac and pulmonary rehab in patient homes. This expands the addressable market for home health agencies and telehealth providers. Addus HomeCare ($ADUS) is the pure-play beneficiary; UnitedHealth ($UNH) gains through both its MA insurance and Optum home health arms. The bill is early-stage — referred to Senate Finance — requiring committee markup and passage before market impact materializes.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S.248 permanently codifies COVID-era telehealth flexibilities for Medicare cardiopulmonary rehab in the home — no new funding, but expands billable service categories for home health agencies.
  • 2.$ADUS is the pure-play beneficiary with 100% home health exposure and near-term revenue potential of $15M–$40M annually.
  • 3.$UNH benefits through both Medicare Advantage cost savings and Optum home health delivery, but effect is diluted across a $500B+ revenue base.
  • 4.Bill is early-stage (referred to Senate Finance) — legislative risk is high; passage probability ~40–50% this Congress.
  • 5.Market impact requires CMS rate-setting post-enactment, typically a 12–24 month lag before revenue realization.

Market Implications

Immediate market reaction is muted given early legislative stage. $ADUS provides direct exposure for investors betting on passage — the stock at $96.96 has not priced in the bill's potential, offering asymmetric upside if the bill advances. $UNH movement is dominated by broader earnings and regulatory news; this bill is a minor positive at the margin. Investors should monitor Senate Finance Committee schedule — a hearing or markup would be the first catalyst to move $ADUS. No short-term trading signal beyond current levels.

Full Analysis

Senator Blackburn (R-TN) introduced S.248 on January 24, 2025, during the 119th Congress. The bill was read twice and referred to the Senate Committee on Finance. It currently has 5 cosponsors and a companion bill, H.R.783, in the House. The bill is in early legislative stages — no hearings, markup, or floor votes have occurred.

The bill amends Section 1861(eee)(2) and Section 1834(m) of the Social Security Act to permanently allow Medicare Part B cardiopulmonary rehabilitation services — including cardiac rehab, intensive cardiac rehab, and pulmonary rehab — to be delivered via real-time audio-video telehealth in the patient's home. Critically, the bill also allows virtual supervision by physicians, PAs, NPs, and CNSs. This codifies flexibilities that were temporary under COVID-19 public health emergency waivers and previous CMS rulemaking. The bill authorizes zero new appropriations — it is a coverage expansion, not a direct spending bill. Market impact depends on CMS rulemaking to set reimbursement rates for home-based delivery, which typically takes 12–24 months post-enactment.

Structural winners are home health agencies and telehealth platform providers. $ADUS is the premier pure-play home health agency (no hospital or insurance exposure) — its entire revenue model is Medicare Part B home health. The bill expands its total addressable patients for a high-margin recurring service line. $UNH benefits through two channels: its UnitedHealthcare Medicare Advantage plans can adopt lower-cost home-based rehab (reducing medical loss ratios), and its Optum home health division can scale service delivery. Diversified hospital operators like $HCA (HCA Healthcare) face mild headwinds if patients shift from hospital outpatient departments to home settings, though the effect is marginal given hospital rehab is a small revenue share.

$ADUS currently trades at $96.96, near the midpoint of its 52-week range ($90.89–$124.44), with a +2.73% gain over 30 days. The stock has not yet priced in this bill's potential — legislative risk remains high at this early stage. $UNH at $370.74 has surged +41.62% over 30 days, driven by broader sector factors (earnings, regulatory clarity) that overwhelm this bill's specific impact. The bill is a positive but marginal tailwind within UNH's massive $500B+ revenue base.

Legislative timeline: S.248 must advance through Senate Finance (Chairman Wyden, D-OR). The companion H.R.783 is in House Energy & Commerce and Ways & Means. Passage probability this Congress is moderate (estimated 40–50%) — the policy is broadly popular (bipartisan, non-controversial coverage expansion), but early-stage bills in a divided 119th Congress face headwinds from competing priorities. If enacted, CMS rulemaking would take 1–2 years before revenue flows begin.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Moderate

Some confirming evidence found across public data sources

Confirmed by:
$$ADUS▲ Bullish
Est. $15.0M$40.0M revenue impact

What the bill does

Permanent expansion of Medicare originating site designation to include the beneficiary's home for cardiac rehabilitation programs, intensive cardiac rehabilitation programs, and pulmonary rehabilitation programs, coupled with authorization for virtual presence of supervising physicians via audio-visual real-time communications technology.

Who must act

Medicare Administrative Contractors (MACs) and home health agencies furnishing cardiopulmonary rehabilitation under Medicare Part B.

What happens

Codifies COVID-era telehealth flexibilities permanently, removing the regulatory sunset risk that has constrained planning and investment in home-based rehab service lines. This expands the addressable market for home health agencies to include Medicare beneficiaries who previously had to travel to a hospital outpatient department for these services.

Stock impact

Addus HomeCare derives ~100% of revenue from home health and hospice services. This bill directly expands the service portfolio Addus can offer to its existing patient base and allows it to capture new patients who would otherwise not be candidates for home-based cardiopulmonary rehab. No capital expenditure required — pure regulatory expansion of billable services.

$$UNH▲ Bullish
Est. $50.0M$200.0M revenue impact

What the bill does

Permanent expansion of Medicare Part B-covered cardiopulmonary rehabilitation to the home via telehealth, codifying the originating site flexibility that allows patient homes to serve as the location of service delivery.

Who must act

Medicare fee-for-service beneficiaries and Medicare Advantage plans administered by UnitedHealthcare (UNH's insurance segment).

What happens

Medicare Advantage plans (UnitedHealthcare is the largest MA insurer with ~31% market share) can now design benefits around permanent home-based cardiopulmonary rehab, reducing facility costs and improving patient adherence. The Optum Health Services arm can also deploy its home health and telehealth infrastructure to deliver these services under MA contracts.

Stock impact

UnitedHealth Group benefits two ways: (1) UnitedHealthcare Medicare Advantage plans reduce medical cost ratios by substituting lower-cost home-based rehab for hospital outpatient visits; (2) Optum's home health division can expand billable service volume under both Medicare FFS and MA contracts. UNH's 30-day price surge (+41.62%) reflects broader sector momentum, but this bill provides a specific tailwind for its Medicare and Optum home health operations.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 23, 2026

Establishing an America First Arms Transfer Strategy

This executive order directs the Secretary of War, along with the Secretaries of State and Commerce, to create an 'America First Arms Transfer Strategy' that prioritizes foreign arms sales to boost U.S. defense industrial base capacity, streamline export processes, and enhance production of key weapons systems. It mandates a sales catalog of prioritized platforms within 120 days, forms a task force to improve coordination, and reforms congressional notification procedures for arms transfers.

Exec OrderJun 22, 2026

Ushering in the Next Frontier of Quantum Innovation

This executive order updates the National Quantum Strategy and establishes a national effort (QC-ADDS) to develop a quantum computer for scientific discovery, with deployment at a Department of Energy facility. It directs multiple agencies to prioritize quantum sensing, networking, and supply chain initiatives, and mandates plans for commercial readiness and national security applications.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →